ABVC BioPharma Amends Financial Statement Reliance Filing
Ticker: ABVC · Form: 8-K/A · Filed: May 2, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K/A |
| Filed Date | May 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-reporting, non-reliance
TL;DR
ABVC BioPharma's financials might be shaky - they're amending a filing about not relying on old reports.
AI Summary
ABVC BioPharma, Inc. filed an 8-K/A on May 2, 2025, to amend a previous filing concerning the non-reliance on previously issued financial statements. This amendment relates to events that occurred on April 15, 2025, indicating a potential issue with their past financial reporting or audit.
Why It Matters
This filing suggests potential inaccuracies in ABVC BioPharma's past financial statements, which could impact investor confidence and the company's reported financial health.
Risk Assessment
Risk Level: medium — Amendments regarding non-reliance on financial statements often signal underlying accounting or reporting issues that could affect the company's valuation.
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- 001-40700 (company) — SEC File Number
- 26-0014658 (company) — IRS Employer Identification No.
- Nevada (company) — State of Incorporation
- April 15, 2025 (date) — Date of earliest event reported
- May 2, 2025 (date) — Date of Report
FAQ
What specific financial statements are no longer reliable?
The filing does not specify which particular financial statements are affected, only that there is a non-reliance on previously issued financial statements or a related audit report or completed interim review.
What is the reason for the non-reliance on previously issued financial statements?
The filing is an amendment to a previous report and does not provide the specific reasons for the non-reliance on the financial statements.
When was the original report filed that this 8-K/A is amending?
The filing does not explicitly state the date of the original report being amended, but it is an 8-K/A filed on May 2, 2025, concerning events as of April 15, 2025.
What is the company's primary business?
ABVC BioPharma, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Has ABVC BioPharma changed its name previously?
Yes, ABVC BioPharma, Inc. was formerly known as American BriVision (Holding) Corp, METU BRANDS, INC., and ECOLOGY COATINGS, INC.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on May 2, 2025 regarding ABVC BIOPHARMA, INC. (ABVC).